We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
-1.48%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$475M
AUM Growth
-$34.1M
Cap. Flow
-$11.9M
Cap. Flow %
-2.51%
Top 10 Hldgs %
32.02%
Holding
95
New
18
Increased
29
Reduced
25
Closed
22

Top Buys

Rank Stock Value
1
GO icon
Grocery Outlet
GO
+$8.02M
2
QTWO icon
Q2 Holdings
QTWO
+$6.19M
3
RGEN icon
Repligen
RGEN
+$6.12M
4
CTLT
CATALENT, INC.
CTLT
+$6.02M
5
NFLX icon
Netflix
NFLX
+$5.48M

Top Sells

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$14M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$9.31M
3
SAGE
Sage Therapeutics
SAGE
+$7.05M
4
OKTA icon
Okta
OKTA
+$6.25M
5
VAC icon
Marriott Vacations Worldwide
VAC
+$5.31M

Sector Composition

Rank Sector Weight
1 Healthcare 23.9%
2 Technology 17.5%
3 Communication Services 13.07%
4 Consumer Discretionary 11.14%
5 Materials 4.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOW icon
51
Lowe's Companies
LOW
$122B
$3.3M 0.69%
+30,000
New +$3.17M
BHVN
52
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$3.17M 0.67%
76,000
-36,893
-33% -$1.56M
TMUS icon
53
T-Mobile US
TMUS
$187B
$2.91M 0.61%
+37,000
New +$2.9M
NVCR icon
54
NovoCure
NVCR
$1.87B
$2.82M 0.59%
37,690
+4,700
+14% +$376K
PODD icon
55
Insulet
PODD
$9.39B
$2.8M 0.59%
+17,000
New +$2.39M
MDCO
56
CALL
DELISTED
Medicines Co
MDCO
$2.6M 0.55%
52,100
+30,000
+136% +$1.2M
PTLA
57
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.52M 0.53%
94,000
-6,000
-6% -$168K
ASND icon
58
Ascendis Pharma A/S
ASND
$16.2B
$2.41M 0.51%
25,000
-16,000
-39% -$1.78M
KRYS icon
59
Krystal Biotech
KRYS
$9.61B
$2.03M 0.43%
+58,319
New +$2.61M
PLAN
60
PUT
DELISTED
Anaplan, Inc.
PLAN
$1.88M 0.4%
+40,000
New +$2.17M
LKFT
61
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.73B
$1.83M 0.39%
12,000
-7,000
-37% -$1.15M
ARNA
62
PUT
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.83M 0.39%
+40,000
New +$2.25M
MRTX
63
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.79M 0.38%
23,000
-24,000
-51% -$2.25M
EW icon
64
Edwards Lifesciences
EW
$52.2B
$1.76M 0.37%
+24,000
New +$1.69M
ZGNX
65
DELISTED
Zogenix, Inc.
ZGNX
$1.72M 0.36%
43,000
+3,000
+8% +$138K
NYT icon
66
New York Times
NYT
$10.7B
$1.54M 0.32%
54,000
-96,000
-64% -$3.03M
ZM icon
67
Zoom
ZM
$29.6B
$1.52M 0.32%
20,000
-17,000
-46% -$1.53M
MDCO
68
PUT
DELISTED
Medicines Co
MDCO
$1.5M 0.32%
+30,000
New +$1.2M
JWN
69
DELISTED
Nordstrom
JWN
$1.35M 0.28%
+40,000
New +$1.22M
OKTA icon
70
PUT
Okta
OKTA
$25.9B
$984K 0.21%
+10,000
New +$1.25M
PTCT icon
71
PTC Therapeutics
PTCT
$5.78B
$853K 0.18%
25,208
-49,792
-66% -$2.17M
TLRY icon
72
PUT
Tilray
TLRY
$607M
$743K 0.16%
+3,000
New +$1.09M
VAC icon
73
Marriott Vacations Worldwide
VAC
$3.4B
$207K 0.04%
2,000
-54,000
-96% -$5.31M
ADVM
74
DELISTED
Adverum Biotechnologies
ADVM
– –
-36,900
Closed -$4.39M
ALLK
75
PUT
DELISTED
Allakos
ALLK
– –
-22,500
Closed -$975K
1 2
3
4

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $797M AUM 28.71% 1-Year Est. Return
Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Atika Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Atika Capital Management held 95 positions worth $475M, down 6.7% from $509M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Atika Capital Management's Q3 2019 filing shows 18 new, 29 increased, 25 reduced and 22 closed positions. Its largest new stake was Grocery Outlet: 211,500 shares worth $7.33M. The largest sale was Sarepta Therapeutics, an estimated $14M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 33% a quarter earlier, followed by Technology and Communication Services.

  • Atika Capital Management's largest Q3 2019 buy was Grocery Outlet: 211,500 shares worth $7.33M.
  • Atika Capital Management added most to Netflix in Q3 2019, an estimated $5.48M increase.
  • Atika Capital Management's biggest Q3 2019 reduction was Okta, cutting an estimated $6.25M.
  • Atika Capital Management fully exited Sarepta Therapeutics in Q3 2019, selling an estimated $14M.
  • Atika Capital Management's ten largest holdings make up 32% of its $475M portfolio in Q3 2019.
  • Atika Capital Management opened 18 new positions and closed 22 in Q3 2019.
  • Atika Capital Management's portfolio value fell 6.7% quarter-over-quarter to $475M.

Based on Atika Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.